What Auvelity trials are people looking for?
Auvelity (dextromethorphan/ bupropion) has been studied in clinical trials for major depressive disorder (MDD). Searches for “Auvelity trials” usually target one of these points: which studies were run, who qualified, what endpoints were measured (like symptom improvement on depression scales), and what the results showed.
What outcomes do Auvelity trials measure in depression studies?
In depression drug trials, the main outcome is typically change from baseline in a standardized depression rating scale (commonly the MADRS or similar measures). Trials also track response (for example, a substantial reduction in scores) and remission (reaching low symptom scores), plus safety and tolerability (side effects, discontinuations, and lab/vital-sign changes).
What patient populations and eligibility criteria are commonly used?
Auvelity trials in MDD generally study adults who meet diagnostic criteria for major depressive disorder and have a baseline level of depressive symptoms severe enough to detect change. Eligibility criteria commonly include exclusion of certain conditions (for example, other primary psychiatric disorders, substance-related conditions, and medical problems that could confound safety or efficacy), as well as medication washout rules.
Where can you find official trial records for Auvelity?
The most reliable way to see a trial’s status, locations, eligibility criteria, and results (when posted) is through clinical trial registries. These records often include NCT numbers, which make it easier to match the public record to journal articles and label-relevant evidence.
Are there Auvelity trials beyond the initial MDD studies?
After initial development, companies and researchers may conduct additional studies, such as longer-term safety assessments, studies in broader subpopulations, or trials evaluating specific dosing strategies. If you tell me whether you mean “Auvelity for depression” specifically or you want trials in another indication, I can narrow the search intent.
Quick next step: which Auvelity trials do you mean?
To point you to the right trial(s), tell me one detail:
1) Do you want the key MDD efficacy trials that supported approval, or
2) a specific trial phase (Phase 2 vs Phase 3), or
3) a particular NCT number you’ve seen, or
4) trials in a specific country (US/EU)?
If you share any identifier (even partial wording like an NCT number), I’ll map it to the corresponding Auvelity study and summarize the results and safety signals.